Friday, June 20, 2025 6/20/2025

NCI Community Oncology Research Program (NCORP) Community Sites

Award Number: UG1CA189852
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2014
PERIOD OF PERFORMANCE END DATE: 07/31/2020

Group Awards By:

View Award Description

NCI Community Oncology Research Program (NCORP) Community Sites - DESCRIPTION (provided by applicant): Main Line Health has access to nearly 1 million people and its service area includes Western Philadelphia, Montgomery, Chester and Delaware Counties of Pennsylvania. Annually, MLH provides care for ~ 3100 new cancer cases, of which approximately 50% of patients are 65 years or older. Main Line Health (MLH) has participated as a NCI CCOP for the past 20 years and has the infrastructure in place to become a NCORP Community Site, Strengthening this infrastructure, MLH is transitioning to a "One Program, Multiple Sites" cancer care organizational model where oversight by a single service line leadership team (clinical and administrative) is accountable for service line performance. Main Line Health long-term goals include: continue to provide state of the art multidisciplinary treatment that improves outcomes and quality of life for our patients; identify and address disparities of care and advancing standards of care. To accomplish these goals, MLH NCORP will continue providing access to NCI-approved clinical trials for cancer prevention, control, screening and treatment. Additionally, MLH NCORP will educate healthcare colleagues and patients about the importance and impact of clinical trials, helping to reduce barriers to accrual MLH will evaluate its cancer care processes, learning what factors outside of a patient's cancer diagnosis may create barriers or impact a patient's well-being. Although Main Line Health does have internal assessment in place, as a NCORP Community site, MLH will be able to evaluate its cancer care and services on a larger scale and report these findings to the physician and patient community and transform care. Main Line Health's existing relationships with the following Research Bases: CALGB (Alliance), ECOG, GOG, IVID Anderson, NSABP, RTOG, and Wake Forest University, help ensure a study portfolio complementary of MLH cancer population and access to important cancer care delivery questions.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2018	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 E LANCASTER AVE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	5	2/9/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2018 ( Subtotal = $641,288 )
2018	2018	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 E LANCASTER AVE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	5	7/31/2018	NON-COMPETING CONTINUATION	$612,003
2018	2018	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 E LANCASTER AVE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	001	5	9/12/2018	NON-COMPETING CONTINUATION	$29,285
														Subtotal = $641,288

Issue Date FY: 2017 ( Subtotal = $601,401 )
2017	2017	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 E LANCASTER AVE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	002	4	8/14/2017	NON-COMPETING CONTINUATION	$37,605
2017	2017	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 E LANCASTER AVE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	001	4	8/3/2017	NON-COMPETING CONTINUATION	$6,198
2017	2017	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 E LANCASTER AVE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	4	7/31/2017	NON-COMPETING CONTINUATION	$557,598
														Subtotal = $601,401

Issue Date FY: 2016 ( Subtotal = $620,783 )
2016	2016	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	3	7/25/2016	NON-COMPETING CONTINUATION	$620,783
														Subtotal = $620,783

Issue Date FY: 2015 ( Subtotal = $626,981 )
2015	2015	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	2	7/31/2015	NON-COMPETING CONTINUATION	$626,981
														Subtotal = $626,981

Issue Date FY: 2014 ( Subtotal = $704,718 )
2014	2014	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	001	1	9/18/2014	NEW	$77,737
2014	2014	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	1	7/31/2014	NEW	$626,981
														Subtotal = $704,718

Grand Total All Awards = $3,195,171

Top

All Categories

About

Search

Reports

Data Submission

Award Information

NCI Community Oncology Research Program (NCORP) Community Sites

Award Number: UG1CA189852

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2014

PERIOD OF PERFORMANCE END DATE: 07/31/2020

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer